These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11138845

  • 1. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
    Waldmeier PC, Spooren WP, Hengerer B.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):526-37. PubMed ID: 11138845
    [Abstract] [Full Text] [Related]

  • 2. Neurorescuing effects of the GAPDH ligand CGP 3466B.
    Waldmeier PC, Boulton AA, Cools AR, Kato AC, Tatton WG.
    J Neural Transm Suppl; 2000 Dec; (60):197-214. PubMed ID: 11205140
    [Abstract] [Full Text] [Related]

  • 3. Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra.
    Andringa G, van Oosten RV, Unger W, Hafmans TG, Veening J, Stoof JC, Cools AR.
    Eur J Neurosci; 2000 Aug; 12(8):3033-43. PubMed ID: 10971644
    [Abstract] [Full Text] [Related]

  • 4. The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey.
    Andringa G, Cools AR.
    J Neural Transm Suppl; 2000 Aug; (60):215-25. PubMed ID: 11205142
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Aug; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 6. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
    Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU.
    Brain Res; 1996 Nov 25; 741(1-2):68-74. PubMed ID: 9001706
    [Abstract] [Full Text] [Related]

  • 7. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 25; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 8. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 25; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.
    Cutillas B, Ambrosio S, Unzeta M.
    Neurosci Lett; 2002 Aug 30; 329(2):165-8. PubMed ID: 12165403
    [Abstract] [Full Text] [Related]

  • 10. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
    Nam MH, Park M, Park H, Kim Y, Yoon S, Sawant VS, Choi JW, Park JH, Park KD, Min SJ, Lee CJ, Choo H.
    ACS Chem Neurosci; 2017 Jul 19; 8(7):1519-1529. PubMed ID: 28332824
    [Abstract] [Full Text] [Related]

  • 11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y, Yoshimura R, Nakai K, Itakura T.
    Brain Res; 2002 Aug 30; 947(2):271-83. PubMed ID: 12176170
    [Abstract] [Full Text] [Related]

  • 12. CGP 3466 increases survival of cultured fetal dopaminergic neurons.
    Matarredona ER, Meyer M, Seiler RW, Widmer HR.
    Restor Neurol Neurosci; 2003 Aug 30; 21(1-2):29-37. PubMed ID: 12808200
    [Abstract] [Full Text] [Related]

  • 13. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease.
    Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V.
    Neuropharmacology; 2014 Apr 30; 79():212-21. PubMed ID: 24291466
    [Abstract] [Full Text] [Related]

  • 14. Rescue of dying neurons by (R)-deprenyl in the MPTP-mouse model of Parkinson's disease does not include restoration of neostriatal dopamine.
    Steyn SJ, Castagnoli K, Castagnoli N.
    Ann N Y Acad Sci; 2001 Jun 30; 939():330-9. PubMed ID: 11462789
    [Abstract] [Full Text] [Related]

  • 15. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease.
    Visanji NP, Orsi A, Johnston TH, Howson PA, Dixon K, Callizot N, Brotchie JM, Rees DD.
    FASEB J; 2008 Jul 30; 22(7):2488-97. PubMed ID: 18364399
    [Abstract] [Full Text] [Related]

  • 16. Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.
    Kreisler A, Duhamel A, Vanbesien-Mailliot C, Destée A, Bordet R.
    Behav Pharmacol; 2010 May 30; 21(3):194-205. PubMed ID: 20440202
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY, Park HJ, Ahn YH, Lee PH.
    J Neurochem; 2009 Nov 30; 111(4):1042-50. PubMed ID: 19765187
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 30; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 19. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ, Rauhala P, Tuominen RK, Liesi P.
    J Neurosci Res; 2006 Aug 15; 84(3):655-65. PubMed ID: 16810683
    [Abstract] [Full Text] [Related]

  • 20. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP, Agid Y.
    Brain Res; 1992 Dec 04; 597(2):233-40. PubMed ID: 1361874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.